Roivant Sciences Ltd. (ROIV) Earnings
NASDAQ·Healthcare·Biotechnology
$39.43
-0.19%
Mkt Cap $29.49B
EPS — Estimate vs Actual
Mkt Cap
$29.49B
P/E
—
Fwd P/E
—
P/S
4130.06
Rev TTM
—
EPS TTM
-$1.10
NASDAQ·Healthcare·Biotechnology
$39.43
-0.19%
Mkt Cap $29.49B
Mkt Cap
$29.49B
P/E
—
Fwd P/E
—
P/S
4130.06
Rev TTM
—
EPS TTM
-$1.10